Clinical Trials Logo

Filter by:
  • Enrolling by invitation  
  • Page [1]
NCT ID: NCT02256514 Enrolling by invitation - Liver Cirrhosis Clinical Trials

Open Label Trial of Immunotherapy for Advanced Liver Cancer

HCC
Start date: September 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate daily dosing of oral immunotherapy hepcortespenlisimut-L (V5) in patients with advanced stage of HCC not amenable to surgical intervention or with recurrent tumor after surgery.